BioSpace News Archive

Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, presented its breakthrough research and therapies to treat age-related diseases to members of the American Society for Aesthetic Plastic Surgery, known as The Aesthetic Society.

Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 RBC Capital Markets Global Healthcare Conference in New York, New York, on Tuesday, May 14, 2024.

ALX Oncology Holdings Inc., an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, announced the appointment of Allison Dillon, Ph.D., as Chief Business Officer.

T2 Biosystems, Inc. announced that it has signed a non-binding letter of intent to enter into a strategic partnership with ECO Laboratory, a Massachusetts-based clinical laboratory certified under the Clinical Laboratory Improvement Amendments.

Thryv Therapeutics Inc. today announced a poster presentation of SGK1 inhibition in models of Drug-Induced QT prolongation at the 2024 Heart Rhythm Society meeting in Boston, MA.

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces the submission to ethics of a trial entitled “A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants.”

Novavax, Inc. today announced it will report its first quarter 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Friday, May 10, 2024.

FibroBiologics, Inc. today announced that Founder and Chief Executive Officer, Pete O’Heeron, will present a corporate update on recent business and clinical developments at the 2024 BIO International Convention, June 3-6, 2024, in San Diego, California.

Dipharma Francis S.r.l. proudly announced that Dipharma Inc., its US facility located in Kalamazoo, MI, has been inspected by the U.S. Food and Drug Administration and has received the Establishment Inspection Report, satisfactorily closing the inspection process.

Albert Einstein College of Medicine has appointed nationally recognized education leader Yoon Kang, M.D., as its inaugural vice dean for education, following a national search.